• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Prescription drug use rising among US Adults

byPriyanka Vedak
November 5, 2015
in Chronic Disease, Public Health
Reading Time: 2 mins read
Publication of pneumonia antibiotic guidelines changed prescribing trends
Share on FacebookShare on Twitter

1. This study found that an increase in prescription drug use among US adults when comparing rates from 1999-2000 to 2011 to 2012.

2. This increase in use was noted in the majority of drug classes that were examined.

Evidence Rating Level: 2 (Good)

Study Rundown: This study aimed to examined prescription drug among US adults using data gathered from the National Health and Nutrition Examination Survey, NHANES. It found an overall increase in prescription drug use among US adults when comparing prescription drug use rates gathered from the survey from 1999-2000 to 2011 to 2012. Of the 18 drug classes examined, a majority (11) demonstrated an increase in use during this time period.

Limitations of this study include its retrospective design and exclusion of institutionalized adults, including those living in nursing homes. Strengths included its reliance on population based survey data rather than indirect markers of prescription drug use such as cost or pharmacy data. This data may be used to examine the effects of policy changes, drug availability, and other events that occurred during this time period on prescription drug use.

Click to read the study in JAMA

RELATED REPORTS

Increased rapid eye movement (REM) sleep is associated with lower risks of several chronic diseases

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Alcohol use declines but remains above pre-pandemic levels

Relevant Reading: Prescription drug use, diagnoses, and healthcare utilization among the elderly

In-Depth [retrospective cohort]: This study used data gathered from the National Health and Nutrition Examination Survey, NHANES, from 1999-2000 to 2011-2012 during household interviews. Participants were asked what prescription drugs they had taken over the past 30 days and were asked to show the bottle or report the name of the medication. 5558 individuals participated overall. While 51% of adults reported prescription drug use in 1999-2000, 59% reported it in 2011-2012 (95% CI, 3.8-12%). 18 drug classes were examined with an increase in use noted in 11 of them, including antihypertensives (20% versus 27%, p<.001), antidepressants (6.8% versus 13%, p<.001), and antihyperlipidemics, (7.6% versus 18%, p<.001)

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Previous Post

Low-fat diets not beneficial over others for long-term weight loss

Next Post

Neoplastic tapeworm cells may invade human tissue in immunocompromised hosts

RelatedReports

Cardiology

Increased rapid eye movement (REM) sleep is associated with lower risks of several chronic diseases

September 23, 2026
Chronic Disease

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

September 22, 2026
Psychiatry

Alcohol use declines but remains above pre-pandemic levels

September 22, 2026
Chronic Disease

High maternal egg-peanut intake not associated with reduced infant allergy

September 22, 2026
Next Post
Neoplastic tapeworm cells may invade human tissue in immunocompromised hosts

Neoplastic tapeworm cells may invade human tissue in immunocompromised hosts

Mutation linked with decrease in cutaneous diffuse large B-cell lymphoma

Lenalidomide plus rituximab may be an effective initial therapy for mantle-cell lymphoma

Epileptogenic foci may be lateralized using functional brain glutamate imaging

Epileptogenic foci may be lateralized using functional brain glutamate imaging

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Increased rapid eye movement (REM) sleep is associated with lower risks of several chronic diseases
  • The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality
  • Alcohol use declines but remains above pre-pandemic levels
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.